Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1α and VEGF

Induction of Apoptosis as a Potential Chemopreventive Effect of Dual Cycloxygenase Inhibitor, Diclofenac, in Early Colon Carcinogenesis

(2012) Sankar Nath Sanyal et al.   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

Modulation of inflammatory changes in early stages of colon cancer through activation of PPARγ by diclofenac

(2010) Jasmeet Kaur et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Alterations in membrane fluidity and dynamics in experimental colon cancer and its chemoprevention by diclofenac

(2010) Jasmeet Kaur et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Intrinsic Mitochondrial Membrane Potential Change and Associated Events Mediate Apoptosis in Chemopreventive Effect of Diclofenac in Colon Cancer

(2010) Jasmeet Kaur et al.   ONCOLOGY RESEARCH

PI3-kinase/Wnt association mediates COX-2/PGE2 pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac

(2010) Jasmeet Kaur et al.   TUMOR BIOLOGY

Role of Lipoxins and Resolvins as Anti-Inflammatory and Proresolving Mediators in Colon Cancer

(2009) Naveena Janakiram et al.   CURRENT MOLECULAR MEDICINE

Significance of monocyte chemoattractant protein-1 in angiogenesis and survival in colorectal liver metastases

(2009) Yoshidome   INTERNATIONAL JOURNAL OF ONCOLOGY